These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 944032)

  • 1. Histochemical studies in experimental portal-systemic encephalopathy.
    Norenberg MD
    Arch Neurol; 1976 Apr; 33(4):265-9. PubMed ID: 944032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperammonemia and hepatic encephalopathy stimulate rat cerebral synaptic mitochondrial glutamate dehydrogenase activity specifically in the direction of glutamate oxidation.
    Faff-Michalak L; Albrecht J
    Brain Res; 1993 Aug; 618(2):299-302. PubMed ID: 8104085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ammonia-induced heme oxygenase-1 expression in cultured rat astrocytes and rat brain in vivo.
    Warskulat U; Görg B; Bidmon HJ; Müller HW; Schliess F; Häussinger D
    Glia; 2002 Dec; 40(3):324-36. PubMed ID: 12420312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Progression and reversal of the disorder.
    Norenberg MD
    Lab Invest; 1977 Jun; 36(6):618-27. PubMed ID: 559221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathy.
    Romero-Gómez M
    Metab Brain Dis; 2005 Dec; 20(4):319-25. PubMed ID: 16382342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential response of enzymes of glutamate metabolism in neuronal perikarya and synaptosomes in acute hyperammonemia in rat.
    Subbalakshmi GY; Murthy CR
    Neurosci Lett; 1985 Aug; 59(1):121-6. PubMed ID: 2864671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperammonemia compromises glutamate metabolism and reduces BDNF in the rat hippocampus.
    Galland F; Negri E; Da Ré C; Fróes F; Strapazzon L; Guerra MC; Tortorelli LS; Gonçalves CA; Leite MC
    Neurotoxicology; 2017 Sep; 62():46-55. PubMed ID: 28506823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral amino acid metabolism in hepatic coma.
    Berl S
    Exp Biol Med; 1971; 4():71-84. PubMed ID: 5162461
    [No Abstract]   [Full Text] [Related]  

  • 9. The astrocyte response in experimental portal-systemic encephalopathy: an electron microscopic study.
    Norenberg MD; Lapham LW
    J Neuropathol Exp Neurol; 1974 Jul; 33(3):422-35. PubMed ID: 4365914
    [No Abstract]   [Full Text] [Related]  

  • 10. The brain in experimental portal-systemic encephalopathy. I. Morphological changes in three animal models.
    Pilbeam CM; Anderson RM; Bhathal PS
    J Pathol; 1983 Aug; 140(4):331-45. PubMed ID: 6875706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glial glutamate transporter in hyperammonemia and hepatic encephalopathy: relation to energy metabolism and glutamatergic neurotransmission.
    Norenberg MD; Huo Z; Neary JT; Roig-Cantesano A
    Glia; 1997 Sep; 21(1):124-33. PubMed ID: 9298855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the enzymes of glutamate metabolism in cortical synaptosomes in methionine sulfoximine toxicity.
    Subbalakshmi GY; Murthy CR
    Life Sci; 1984 Jul; 35(2):119-25. PubMed ID: 6146087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease.
    Hadjihambi A; De Chiara F; Hosford PS; Habtetion A; Karagiannis A; Davies N; Gourine AV; Jalan R
    Hepatology; 2017 Apr; 65(4):1306-1318. PubMed ID: 28066916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental studies of the pathomechanism of portal encephalopathy. I. Changes in monoamine oxidase (MAO) activity in the cerebral cortex and cerebellum of rats after portacaval shunt].
    Rokicki W; Rokicki M; Kamiński K; Peciak B; Gebska E
    Neuropatol Pol; 1989; 27(2):199-207. PubMed ID: 2626178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy.
    Görg B; Karababa A; Shafigullina A; Bidmon HJ; Häussinger D
    Glia; 2015 Jan; 63(1):37-50. PubMed ID: 25092802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute hepatic encephalopathy and in vitro treatment with ammonia on glutamate oxidation in bulk-isolated astrocytes and mitochondria of the rat brain.
    Wysmyk-Cybula U; Faff-Michalak L; Albrecht J
    Acta Neurobiol Exp (Wars); 1991; 51(5-6):165-9. PubMed ID: 1687972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On mechanisms in hyperammonemic coma--with particular reference to hepatic encephalopathy.
    Hindfelt B
    Ann N Y Acad Sci; 1975 Apr; 252():116-23. PubMed ID: 238449
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebral metabolic disturbances in the brain during acute liver failure: from hyperammonemia to energy failure and proteolysis.
    Ott P; Clemmesen O; Larsen FS
    Neurochem Int; 2005 Jul; 47(1-2):13-8. PubMed ID: 15921824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats.
    Vogels BA; Maas MA; Daalhuisen J; Quack G; Chamuleau RA
    Hepatology; 1997 Apr; 25(4):820-7. PubMed ID: 9096582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ammonia metabolism in the CNS.
    Kvamme E
    Prog Neurobiol; 1983; 20(1-2):109-32. PubMed ID: 6141592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.